![Matthew J. LeBlanc](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew J. LeBlanc
Plus aucun poste en cours
Provenance du réseau au premier degré de Matthew J. LeBlanc
Entité | Type d'entité | Industrie | |
---|---|---|---|
Salomon Smith Barney, Inc.
57
| Extinct | Investment Banks/Brokers | 57 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Matthew J. LeBlanc via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Masters Business Admin Undergraduate Degree | |
New York University | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
Northwestern University
![]() Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Masters Business Admin | |
Barclays Capital, Inc.
![]() Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Investment Banks/Brokers | Analyst-Fixed Income Corporate Officer/Principal | |
University of Virginia | College/University | Undergraduate Degree Undergraduate Degree | |
Credit Suisse Securities (USA) LLC (Broker)
![]() Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity | |
Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
Stanford University | College/University | Masters Business Admin Undergraduate Degree | |
The California State University | College/University | Undergraduate Degree Undergraduate Degree | |
Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
The University of Chicago | College/University | Masters Business Admin Graduate Degree | |
Oppenheimer & Co., Inc. (Broker)
![]() Oppenheimer & Co., Inc. (Broker) Investment Banks/BrokersFinance Oppenheimer & Co., Inc. (Broker) (Oppenheimer-Broker) is the global full-service brokerage division of Oppenheimer & Co., Inc., an investment boutique headquartered in New York City with additional offices nationwide. Founded in 1975, the firm is owned directly by Viner Finance Inc., an indirect subsidiary of Oppenheimer Holdings Inc. (NYSE: OPY). Oppenheimer-Broker offers a full array of brokerage services to retail, institutional, and corporate clients. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
H.I.G Capital LLC (Private Equity)
![]() H.I.G Capital LLC (Private Equity) Investment ManagersFinance H.I.G. Capital LLC (H.I.G Capital) is a private equity division of H.I.G. Capital LLC founded in 1993 by Sami W Mnaymneh and Anthony A Tamer. The firm is headquartered in Miami, Florida with offices in Europe, Latin America and Middle East. | Investment Managers | Private Equity Investor Private Equity Investor | |
University of Southern California
![]() University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Masters Business Admin Graduate Degree | |
Kymab Ltd.
![]() Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member | |
Kymab Group Ltd.
![]() Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member | |
Calliditas Therapeutics Suisse SA
![]() Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Director/Board Member | |
GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member | |
MedDay Pharmaceuticals SAS
![]() MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer | |
ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
MORGAN STANLEY | Investment Managers | Corporate Officer/Principal | |
STJ Advisors LLP
![]() STJ Advisors LLP Investment ManagersFinance STJ Advisors LLP provides capital markets advisory services. The private company is based in London, UK and has subsidiaries in Hong Kong. The British company was founded in 2008 by John James Moore St. John. | Investment Managers | Corporate Officer/Principal | |
INNATE PHARMA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Yale University | College/University | Graduate Degree | |
Dr. Reddy's Research & Development BV
![]() Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
ABLYNX | Biotechnology | Director/Board Member | |
OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member | |
Creabilis SA | Director/Board Member | ||
First Eagle Investment Management LLC
![]() First Eagle Investment Management LLC Investment ManagersFinance First Eagle Investment Management LLC (FEIM) is a SEC-registered investment advisor and holding firm headquartered in New York City. The firm was founded in 1864 and formerly known as Arnhold & S. Bleichroeder Advisers, Inc. FEIM provides investment advisory services primarily to mutual funds, private funds, collective investment trusts and institutional separately managed accounts (SMAs), as well as to a registered, closed-end interval fund. The firm serves as the investment adviser to the First Eagle Funds, First Eagle Variable Funds and to the First Eagle Credit Opportunities Fund, which are registered investment companies. | Investment Managers | Corporate Officer/Principal | |
Michigan State University | College/University | Undergraduate Degree | |
Natixis Securities Americas LLC
![]() Natixis Securities Americas LLC Investment Banks/BrokersFinance Founded in 2002, Natixis Securities Americas LLC is an investment bank and SEC-registered broker/dealer headquartered New York City with offices in several leading U.S. cities and affiliate offices in London and Paris. The firm is a division of Natixis and a subsidiary of Natixis SA. Their client base is located throughout North America and Europe and ranges from the largest mutual fund and pension fund managers to specialist hedge funds. Natixis Securities Americas' sales and trading teams are located in New York, Boston, Los Angeles and Houston. Natixis Securities Americas' research efforts focus on identifying new insights about companies that are not fully reflected in their stock prices. The firm also seeks to provide clients with access to the managements of listed companies and to other industry experts. They arrange for such marketing opportunities, in the form of road shows, conferences, meetings and conference calls. Natixis Securities Americas' institutional trading desk offers clients trading capabilities in equities all over the world. The firm focuses on specific global markets to provide clients with the best possible execution worldwide. Natixis Securities Americas employs a transatlantic approach that examines the effects of technological, market and regulatory developments across both continents on the companies under coverage. In the U.S., they provide in-depth sector coverage on energy (oil services, exploration and production, alternative energy and coal), healthcare (large-cap pharmaceuticals, specialty pharmaceuticals, biotechnology, medical devices and healthcare services) and media (media conglomerates, content creators, interactive TV and new media, as well as technical analysis. In Europe, Natixis Securities Americas applies a country-wide approach to all of the key sectors of France, Germany, Austria and Central and Eastern Europe. Combined, the firm's product offering includes more than 600 stocks. Natixis Securities Americas global trading group specializes in the trading, execution and settlement of international equities. The firm provides 24-hour access to 55 global markets. They cater to broker/dealer and institutional clients, providing ADR and ordinary share executions on an agency or proprietary basis. The firm can accommodate most client trading requirements from basket trading to block orders. To complement their international trading reach, Natixis Securities Americas domestic bulletin board trading group currently markets over 2000 U.S.-based companies. The firm offers their clients innovative trading technology through a proprietary Direct Market Access (DMA) platform, Enabler Direct. This product allows immediate access to a variety of liquidity sources through one anonymous interface. Natixis Securities Americas' global brokerage services group offers services to a select group of professional clients. The firm seeks to partner with banks, broker/dealers, hedge funds and high net-worth clients that can utilize their blend of international capabilities and traditional brokerage services to support and enhance their success. Their global brokerage services group is prominent in international securities, equity trading and brokerage operations in over 55 countries around the world. They have experience in both the pre-trade and post-trade requirements in each of these countries. | Investment Banks/Brokers | Corporate Officer/Principal |
Statistiques
Internationale
Etats-Unis | 33 |
Royaume-Uni | 6 |
France | 5 |
Espagne | 3 |
Danemark | 3 |
Sectorielle
Finance | 18 |
Consumer Services | 17 |
Health Technology | 17 |
Opérationnelle
Director/Board Member | 178 |
Corporate Officer/Principal | 165 |
Undergraduate Degree | 54 |
Analyst-Equity | 53 |
Independent Dir/Board Member | 51 |
Relations les plus connectées
Insiders | |
---|---|
Michael Carpenter | 42 |
Franklin Berger | 41 |
Hans Morris | 30 |
Catherine Moukheibir | 29 |
Aron Schwartz | 27 |
Vincent Cubbage | 22 |
Shao Mu Guo | 19 |
Daniel Leonard Spears | 16 |
Dave M. DiFranco | 15 |
W. Turner | 14 |
Bobby J. Sheth | 11 |
Charles Rhyee | 10 |
Michael A. Barzyk | 9 |
Bradford A. Adams | 9 |
Gustavo Adrian Ferraro | 9 |
- Bourse
- Insiders
- Matthew J. LeBlanc
- Connexions Sociétés